Comparison of day‐to‐day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study

Chia, Yook Chin; Kario, Kazuomi; Tomitani, Naoko; Park, Sungha; Shin, Jinho; Turana, Yuda; Tay, Jam Chin; Buranakitjaroen, Peera; Chen, Chen Huan; Hoshide, Satoshi; Nailes, Jennifer; Minh, Huynh Van; Siddique, Saulat; Sison, Jorge; Soenarta, Arieska Ann; Sogunuru, Guru Prasad; Sukonthasarn, Apichard; Teo, Boon Wee; Verma, Narsingh; Zhang, Yuqing; Wang, Tzung‐Dau

doi:10.1111/jch.13731

Cited by 5 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, high SBP variability may serve as a marker, rather than an independent risk factor, for these conditions. In our study, we similarly observed that the prevalence of diabetes mellitus increased with every quartile, concurring with the results of other studies [19,20] showing that diabetes is associated with autonomic dysfunction manifested as high BP variability.…”

Section: Discussionsupporting

confidence: 93%

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

Anisetti,

Youssef,

Elkhair

et al. 2023

Neurol Neurochir Pol.

View full text Add to dashboard Cite

Introduction.Long-term variability in systolic blood pressure (SBP) is associated with a higher risk of cardiovascular events. Little is known about any association between within-visit SBP variability, stroke, coronary heart disease (CHD), and cardiovascular (CV) death. Material and methods.Participants included adults ≥ 18 years who participated in the US National Health and Nutrition Examination Surveys from 1999 to 2012 linked to the national death index in 2012. Stroke was self-reported. SBP was obtained up to four times by a physician, using a manual sphygmomanometer according to standard procedures. Within-visit SBP variability was defined as the standard deviation of the BP measurements, stratified into quartiles. We evaluated the relationship between within-visit SBP variability and the odds of stroke or CHD using multivariable logistic regression, and with CV mortality, using multivariable Cox regression.Results. Of the 27,987 adults, 16.4% were aged ≥ 65 years, 51.3% were female, 71.2% were white, and 10.7% were black. Factors associated with higher mean SBP variability included older age, hypertension, chronic kidney disease, peripheral artery disease, and smoking (all p < 0.05). The prevalence of stroke significantly increased across SBP variability quartiles, from 2.1% for quartile 1 to 3.7% for quartile 4 (p < 0.001). High SBP variability was associated with higher odds of stroke [odds ratio (OR) 1.8, 95% confidence interval (CI) 1.4-2.2], coronary heart disease (OR 2.0, 95% CI 1.6-2.4), and increased risk of CV mortality [hazard ratio (HR) 2.7, 95% CI 2.3-3.1]. The relationships were not observed after adjusting for covariables.Conclusions. Within-visit variability in SBP is associated with increased risks of stroke, coronary heart disease, and cardiovascular mortality, but the relationship is confounded by age and covariates.

show abstract

Section: Discussionsupporting

confidence: 93%

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

Anisetti,

Youssef,

Elkhair

et al. 2023

Neurol Neurochir Pol.

View full text Add to dashboard Cite

show abstract

“…The HOPE Asia Network has published a number of papers on important Asia‐specific topics in hypertension . This Asia‐specific issue of the Journal of Clinical Hypertension provides an important resource including original research and review articles on the management of hypertension from a variety of Asian viewpoints, including topics such as central BP, environmental factors, comorbidities such as diabetes, atrial fibrillation, heart failure, and dementia, recent Asian guidelines and so forth . This issue also includes reports from twelve countries/regions in Asia to help define and highlight the current status of hypertension, its management, and their initiatives.…”

Section: Resultsmentioning

confidence: 99%

“…The “perfect 24‐hour BP control” strategy taking Asian characteristics into account is essential for achievement of the “zero” cardiovascular event goal . Considerable work has already been done on the journey to achieving this goal . Practically, a staged approach to the 24‐hour management of hypertension should be considered, first targeting morning hypertension, then nocturnal hypertension, followed by daytime hypertension .…”

Section: Perspectivesmentioning

confidence: 99%

The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020

Kario

2020

J of Clinical Hypertension

Self Cite

View full text Add to dashboard Cite

The impact of hypertension-related cardiovascular disease and target organ damage, and therefore the benefits of blood pressure (BP) control, is greater in Asian than in Western countries. Asia-specific features of hypertension and its effective management are important and active areas of research. The Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network was formed in 2016and is now a member of the World Hypertension League. The main goal of the HOPE Asia Network is to improve the management of hypertension and organ protection toward achieving "zero" cardiovascular events in Asia. Considerable work has already been done on the journey to achieving this goal. We have shown that BP control status in Asia differs between countries, and even between regions within the same country. Several expert panel consensus recommendations and clinical guidance papers are available to support the use of home and ambulatory BP monitoring in the region. In addition, the AsiaBP@Home study prospectively investigated home BP control status across 15 specialist centers using the same validated device and measurement schedule. We have also proposed the concept of systemic hemodynamic atherothrombotic syndrome (SHATS), a vicious cycle of BP variability and vascular disease on cardiovascular events and organ damage, and suggested a SHATS score for risk stratification for clinical practice. This special issue of the journal collates Asia-specific resources and data, contributing to advances in hypertension management and cardiovascular disease prevention in the region.

show abstract

“…Increased variability in day-to-day blood pressure and heart rate is predictive of cardiovascular mortality, including left ventricular hypertrophy, coronary heart disease, and stroke, and may also reflect an underlying disease state [77,78]. This study excluded individuals with ischemic heart disease and atrial fibrillation, which was a limitation.…”

Section: Natriuretic Peptidesmentioning

confidence: 99%

Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review

Liu,

Yang,

Lip

et al. 2024

Biomedicines

View full text Add to dashboard Cite

Hypertension (HT) is a disease that poses a serious threat to human health, mediating organ damage such as the cardiovascular (CV) system, kidneys, central nervous system (CNS), and retinae, ultimately increasing the risk of death due to damage to the entire vascular system. Thus, the widespread prevalence of hypertension brings enormous health problems and socioeconomic burdens worldwide. The goal of hypertension management is to prevent the risk of hypertension-mediated organ damage and excess mortality of cardiovascular diseases. To achieve this goal, hypertension guidelines recommend accurate monitoring of blood pressure and assessment of associated target organ damage. Early identification of organ damage mediated by hypertension is therefore crucial. Plasma biomarkers as a non-invasive test can help identify patients with organ damage mediated by hypertension who will benefit from antihypertensive treatment optimization and improved prognosis. In this review, we provide an overview of some currently available, under-researched, potential plasma biomarkers of organ damage mediated by hypertension, looking for biomarkers that can be detected by simple testing to identify hypertensive patients with organ damage, which is of great significance in clinical work. Natriuretic peptides (NPs) can be utilized as a traditional biomarker to detect hypertension-mediated organ damage, especially for heart failure. Nevertheless, we additionally may need to combine two or more plasma biomarkers to monitor organ damage in the early stages of hypertension.

show abstract

Comparison of day‐to‐day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study

Cited by 5 publications

References 28 publications

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020

Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review

Contact Info

Product

Resources

About